Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion
Read MoreMerck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion
Read MoreSwiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs.
Read MoreBoth valuations and economic indicators are "flashing amber lights," says Brian Arcese of Foord Asset Management. Source link
Read MoreQuestions about whether Eli Lilly and Novo Nordisk can maintain their duopoly in weight loss drugs are fair game, but
Read MoreEuropean markets closed higher on Friday as a global stock selloff eased and investors reacted to U.S. inflation data. Source
Read MoreCounterfeit diabetes test strips have been sold on Amazon and shipped to patients across the U.S., said biotech company Roche.
Read MoreThe weekly injection helped patients with obesity lose 18.8% of their weight relative to those who received a placebo, after
Read More"There could … be a greater tailwind for European equities than those in the U.S.," Michael Field says. Source link
Read MoreRoche lowered its 2024 growth outlook in February as it continues to confront a drop-off in demand for its Covid-19
Read More